Nifty
Sensex
:
:
22368.00
73738.45
31.60 (0.14%)
650.12 (0.89%)

Pharmaceuticals & Drugs

Rating :
62/99

BSE: 506128 | NSE: Not Listed

127.15
23-Apr-2024
  • Open
  • High
  • Low
  • Previous Close
  •  132.00
  •  134.00
  •  124.80
  •  130.15
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  206
  •  22.28
  •  167.90
  •  55.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 146.04
  • 16.59
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 193.67
  • N/A
  • 2.10

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 72.30%
  • 0.55%
  • 24.44%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 2.71%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.35
  • 9.03
  • 23.00

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.75
  • 17.60
  • 18.23

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.27
  • 21.17
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.71
  • 10.01
  • 10.70

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.16
  • 1.11
  • 1.46

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.97
  • 7.18
  • 7.13

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Net Sales
50.99
46.82
8.91%
42.61
43.14
-1.23%
48.74
36.74
32.66%
40.91
47.91
-14.61%
Expenses
45.02
39.45
14.12%
37.33
37.57
-0.64%
42.25
31.43
34.43%
36.17
40.90
-11.56%
EBITDA
5.97
7.38
-19.11%
5.29
5.56
-4.86%
6.50
5.31
22.41%
4.74
7.01
-32.38%
EBIDTM
11.71%
15.75%
12.40%
12.90%
13.33%
14.46%
11.58%
14.63%
Other Income
0.10
0.08
25.00%
0.22
0.30
-26.67%
0.24
0.12
100.00%
0.27
0.21
28.57%
Interest
1.35
1.30
3.85%
1.43
1.20
19.17%
1.16
1.26
-7.94%
1.19
1.37
-13.14%
Depreciation
1.78
1.74
2.30%
1.74
1.55
12.26%
1.60
1.66
-3.61%
1.59
2.00
-20.50%
PBT
2.94
4.42
-33.48%
2.34
3.11
-24.76%
3.98
2.52
57.94%
2.23
3.85
-42.08%
Tax
0.76
1.26
-39.68%
0.47
1.01
-53.47%
0.65
0.58
12.07%
0.79
4.01
-80.30%
PAT
2.18
3.16
-31.01%
1.87
2.10
-10.95%
3.33
1.93
72.54%
1.44
-0.15
-
PATM
4.27%
6.74%
4.39%
4.88%
6.83%
5.26%
3.52%
-0.32%
EPS
1.89
3.70
-48.92%
1.63
1.83
-10.93%
2.89
1.97
46.70%
1.25
-0.15
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
183.25
167.61
163.03
90.06
95.31
108.78
105.50
94.81
71.18
102.75
68.57
Net Sales Growth
4.95%
2.81%
81.02%
-5.51%
-12.38%
3.11%
11.28%
33.20%
-30.73%
49.85%
 
Cost Of Goods Sold
100.76
88.82
89.64
41.76
45.28
52.71
54.90
49.94
37.80
66.91
40.30
Gross Profit
82.49
78.79
73.39
48.30
50.04
56.07
50.60
44.87
33.38
35.83
28.27
GP Margin
45.02%
47.01%
45.02%
53.63%
52.50%
51.54%
47.96%
47.33%
46.90%
34.87%
41.23%
Total Expenditure
160.77
144.62
140.00
80.11
88.89
98.56
95.76
82.41
61.21
90.73
60.29
Power & Fuel Cost
-
5.37
5.24
4.29
4.12
3.13
2.99
3.27
2.11
2.45
1.96
% Of Sales
-
3.20%
3.21%
4.76%
4.32%
2.88%
2.83%
3.45%
2.96%
2.38%
2.86%
Employee Cost
-
20.05
17.43
13.68
14.08
13.06
11.68
9.22
7.46
7.72
6.87
% Of Sales
-
11.96%
10.69%
15.19%
14.77%
12.01%
11.07%
9.72%
10.48%
7.51%
10.02%
Manufacturing Exp.
-
21.73
19.86
13.97
17.03
15.53
13.96
14.24
9.04
8.66
6.92
% Of Sales
-
12.96%
12.18%
15.51%
17.87%
14.28%
13.23%
15.02%
12.70%
8.43%
10.09%
General & Admin Exp.
-
6.32
5.06
4.69
5.80
5.99
6.29
4.36
3.27
2.82
2.36
% Of Sales
-
3.77%
3.10%
5.21%
6.09%
5.51%
5.96%
4.60%
4.59%
2.74%
3.44%
Selling & Distn. Exp.
-
2.00
2.20
1.36
1.38
6.80
4.20
0.98
0.95
1.34
1.57
% Of Sales
-
1.19%
1.35%
1.51%
1.45%
6.25%
3.98%
1.03%
1.33%
1.30%
2.29%
Miscellaneous Exp.
-
0.32
0.58
0.36
1.20
1.34
1.74
0.41
0.57
0.83
1.57
% Of Sales
-
0.19%
0.36%
0.40%
1.26%
1.23%
1.65%
0.43%
0.80%
0.81%
0.44%
EBITDA
22.50
22.99
23.03
9.95
6.42
10.22
9.74
12.40
9.97
12.02
8.28
EBITDA Margin
12.28%
13.72%
14.13%
11.05%
6.74%
9.40%
9.23%
13.08%
14.01%
11.70%
12.08%
Other Income
0.83
0.77
0.33
0.21
0.67
2.11
1.34
0.99
0.70
0.81
1.10
Interest
5.13
4.95
5.23
5.08
4.60
3.89
4.32
4.92
4.29
4.40
3.65
Depreciation
6.71
6.53
5.87
5.16
4.46
3.82
3.74
3.75
2.90
2.99
2.10
PBT
11.49
12.28
12.26
-0.08
-1.97
4.62
3.02
4.71
3.48
5.44
3.64
Tax
2.67
3.65
4.01
0.28
0.95
1.31
1.97
1.02
0.97
1.18
0.91
Tax Rate
23.24%
29.72%
32.71%
-350.00%
-48.22%
28.35%
65.23%
21.66%
27.87%
21.69%
26.69%
PAT
8.82
8.62
8.24
-0.36
-2.92
3.30
1.06
3.68
2.50
4.25
2.48
PAT before Minority Interest
8.81
8.63
8.26
-0.36
-2.92
3.31
1.06
3.69
2.51
4.26
2.49
Minority Interest
-0.01
-0.01
-0.02
0.00
0.00
-0.01
0.00
-0.01
-0.01
-0.01
-0.01
PAT Margin
4.81%
5.14%
5.05%
-0.40%
-3.06%
3.03%
1.00%
3.88%
3.51%
4.14%
3.62%
PAT Growth
25.28%
4.61%
-
-
-
211.32%
-71.20%
47.20%
-41.18%
71.37%
 
EPS
7.67
7.50
7.17
-0.31
-2.54
2.87
0.92
3.20
2.17
3.70
2.16

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
62.15
48.19
32.54
32.80
35.73
32.51
31.37
27.64
25.14
20.89
Share Capital
11.49
9.81
8.50
8.50
8.50
8.50
8.50
8.50
8.50
8.50
Total Reserves
50.67
36.55
24.04
24.29
27.23
24.01
22.86
19.14
16.63
12.39
Non-Current Liabilities
19.77
24.21
19.26
21.83
22.58
17.60
17.65
22.81
26.62
21.56
Secured Loans
12.02
17.41
13.94
19.12
16.19
11.70
12.57
13.72
16.45
16.73
Unsecured Loans
0.00
0.00
0.03
0.03
5.39
5.00
4.51
8.59
9.18
3.55
Long Term Provisions
0.51
0.47
0.26
0.27
0.29
0.23
0.38
0.00
0.14
0.09
Current Liabilities
63.04
80.98
54.37
52.46
36.29
37.19
36.45
28.90
31.02
40.89
Trade Payables
14.76
22.08
6.23
10.86
7.26
7.68
7.67
3.09
9.27
22.39
Other Current Liabilities
14.43
15.56
11.65
13.45
13.31
14.47
13.12
11.27
8.06
6.99
Short Term Borrowings
33.27
42.70
36.43
28.11
15.69
15.03
15.65
13.05
12.09
10.32
Short Term Provisions
0.58
0.64
0.06
0.03
0.04
0.02
0.01
1.50
1.59
1.19
Total Liabilities
145.07
153.47
106.25
107.16
94.68
87.37
85.53
79.40
82.83
83.38
Net Block
76.81
71.95
59.66
57.68
51.06
43.70
47.32
37.85
36.10
35.70
Gross Block
108.00
97.25
79.40
72.73
61.65
50.47
51.07
58.88
54.55
51.15
Accumulated Depreciation
31.20
25.30
19.73
15.05
10.59
6.77
3.75
21.03
18.45
15.45
Non Current Assets
84.01
78.70
67.02
61.55
57.79
50.91
54.66
48.84
44.85
37.48
Capital Work in Progress
2.33
3.34
4.91
2.91
0.14
0.00
0.00
2.44
0.95
0.55
Non Current Investment
0.16
0.22
0.22
0.22
0.21
0.23
0.34
0.91
0.86
0.86
Long Term Loans & Adv.
4.71
3.14
2.18
0.73
6.37
6.98
7.00
7.64
6.94
0.37
Other Non Current Assets
0.00
0.05
0.04
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
57.32
71.03
39.24
45.61
36.90
36.46
30.87
30.57
37.96
45.90
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
21.69
19.93
10.79
11.15
8.47
7.67
7.94
6.63
7.03
15.83
Sundry Debtors
27.89
38.08
16.71
23.08
19.18
18.66
18.66
19.42
23.50
24.90
Cash & Bank
2.78
5.78
1.27
1.30
0.60
1.61
1.13
0.38
2.36
0.91
Other Current Assets
4.96
0.00
3.91
3.95
8.64
8.52
3.14
4.14
5.07
4.26
Short Term Loans & Adv.
4.96
7.24
6.57
6.13
4.73
4.51
3.14
4.14
5.07
4.24
Net Current Assets
-5.72
-9.95
-15.13
-6.84
0.61
-0.73
-5.58
1.66
6.95
5.01
Total Assets
141.33
149.73
106.26
107.16
94.69
87.37
85.53
79.41
82.82
83.39

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Cash From Operating Activity
20.91
8.55
6.31
8.75
8.72
12.88
16.05
3.49
-0.25
-0.15
PBT
12.28
12.26
-0.08
-1.97
4.62
3.02
4.71
3.48
5.44
3.41
Adjustment
11.58
11.05
10.23
8.97
7.70
9.60
8.78
3.04
3.00
2.34
Changes in Working Capital
-0.09
-14.53
-3.08
2.81
-2.21
0.91
3.91
-1.90
-6.63
-5.14
Cash after chg. in Working capital
23.77
8.78
7.07
9.82
10.12
13.53
17.40
4.62
1.81
0.61
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-2.86
-0.24
-0.76
-1.07
-1.40
-0.65
-1.35
-1.13
-2.06
-0.76
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-9.92
-16.50
-6.56
-13.33
-11.15
-5.18
-10.22
-6.18
-3.79
-5.77
Net Fixed Assets
-0.06
0.00
0.00
0.00
0.00
6.02
9.34
0.32
-0.09
-0.15
Net Investments
0.04
0.00
0.00
0.00
-0.05
0.11
0.58
0.00
0.00
0.00
Others
-9.90
-16.50
-6.56
-13.33
-11.10
-11.31
-20.14
-6.50
-3.70
-5.62
Cash from Financing Activity
-14.07
12.13
0.05
5.03
1.42
-7.18
-5.45
0.72
5.50
6.25
Net Cash Inflow / Outflow
-3.08
4.18
-0.21
0.44
-1.01
0.53
0.38
-1.97
1.45
0.33
Opening Cash & Equivalents
4.36
0.18
0.39
-0.05
0.96
0.43
0.05
2.36
0.91
0.58
Closing Cash & Equivalent
1.28
4.36
0.18
0.39
-0.05
0.96
0.43
0.38
2.36
0.91

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
54.11
47.24
38.26
38.56
42.01
38.23
36.88
32.50
29.55
24.55
ROA
5.78%
6.36%
-0.34%
-2.89%
3.63%
1.22%
4.48%
3.09%
5.12%
3.47%
ROE
15.91%
20.93%
-1.11%
-8.51%
9.69%
3.31%
12.51%
9.50%
18.50%
12.70%
ROCE
15.20%
17.34%
5.83%
3.27%
11.59%
10.49%
13.73%
11.47%
16.35%
14.16%
Fixed Asset Turnover
1.63
1.85
1.18
1.42
1.94
2.08
1.72
1.26
1.95
1.44
Receivable days
71.83
61.33
80.64
80.93
63.50
64.56
73.29
109.98
85.55
100.64
Inventory Days
45.31
34.39
44.46
37.57
27.08
27.01
28.05
35.01
40.41
57.75
Payable days
75.70
57.63
74.68
73.02
28.47
30.58
24.08
38.03
64.80
94.19
Cash Conversion Cycle
41.44
38.08
50.42
45.48
62.11
60.99
77.26
106.96
61.17
64.20
Total Debt/Equity
0.82
1.41
1.71
1.54
1.17
1.13
1.26
1.51
1.63
1.60
Interest Cover
3.48
3.34
0.98
0.57
2.19
1.70
1.96
1.81
2.24
1.93

Top Investors:

News Update:


  • Parnax Lab - Quarterly Results
    13th Feb 2024, 16:45 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.